A randomized, double-blind, placebo-controlled trial of the effects of rofecoxib, a selective cylooxygenase-2 inhibitor, on rectal polyps in familial adenomatous polyposis patients. - Higuchi,T.; Iwama,T.; Yoshinaga,K. (Clin Cancer Res, 2003)